Director, Clinical Microbiology Laboratory, Associate Director, Division of Clinical Pathology, Professor of Pathology, University of Michigan
BIOGRAPHY
AUG 26, 2020 11:00 AM PDT | AUGUST 27, 11:00 AM SGT | AUGUST 27, 4:00 PM CEST
SARS-CoV-2 Quality Control for Molecular and Serology assays
Presented at:
A Bio-Rad Quality Control Virtual Conference
Speakers
-
Elitza S. Theel, PhD, D(ABMM)
Director, Infectious Diseases Serology Laboratory, Clinical Microbiology Division, Department of Laboratory Medicine and Pathology, the Mayo Clinic, MinnesotaBIOGRAPHY
Abstract
SARS-CoV-2 has created significant challenges for laboratories, requiring the development, validation, and scale up of testing in a very short time period--often this was done for multiple methods due to capacity demands and supply chain shortages. Part of assuring quality test results is the confidence in testing that comes from a robust QC Program. In this webinar, the speakers will discuss different issues to be considered for QC material selection, as well as QC program design & strategies for SARS-CoV-2 molecular and serology testing.
Learning Objectives:
1. Describe approaches to quality control for SARS-CoV-2 molecular testing that monitor the entire testing process
2. Discuss quality control approaches for high-throughput SARS-CoV-2 antibody tests
3. List 2 optimal QC practices for each methodology
Resources:
SARS-CoV-2 Quality Control for Molecular and Serology Assays Handout
Q&A Sessions SARS-CoV-2 Quality Control for Molecular and Serology Assays